Original Research
Published on 23 Jul 2025
Synergistic effects of combined hypnotic drugs on sleep in mice
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1596813
- 2,331 views
Type at least 3 characters
2,620 articles
articles
Original Research
Published on 23 Jul 2025
S-ketamine facilitates motor function recovery after brachial plexus root avulsion and reimplantation in mice
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1630158
- 2,089 views
Review
Published on 23 Jul 2025
Harnessing nanotechnology for stem-cell therapies: revolutionizing neurodegenerative disorder treatments – a state-of-the-art update
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1630475
- 3,699 views
Original Research
Published on 22 Jul 2025
Cannabidiol reduces synaptic strength and neuronal firing in layer V pyramidal neurons of the human cortex with drug-resistant epilepsy
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1627465
- 2,457 views
- 1 citation
Original Research
Published on 21 Jul 2025
Preclinical pharmacology of alogabat: a novel GABAA-α5 positive allosteric modulator targeting neurodevelopmental disorders with impaired GABAA signaling
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1626078
- 3,761 views
Mini Review
Published on 21 Jul 2025
Pharmacogenetics or predictive genetics? APOE testing blurs the lines
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1627239
- 2,514 views
Opinion
Published on 18 Jul 2025
Several endocannabinoids and amino acids may be biosynthetically converted to catecholamines in vivo
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1614460
- 1,866 views
- 1 citation
Review
Published on 18 Jul 2025
Genetic implication of GABAB receptors in the etiology of neurological and psychiatric disorders
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1634128
- 3,125 views
Correction
Published on 18 Jul 2025
Correction: The antipsychotics functional index (AFI) in schizophrenia
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1662228
- 724 views
Review
Published on 16 Jul 2025
Pharmacological mechanisms and potential clinical applications of Dihydromyricetin in neurological disorders
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1618623
- 2,450 views
Review
Published on 16 Jul 2025
Cerebral ischemia-reperfusion injury: mechanisms and promising therapies
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1613464
- 7,186 views
- 5 citations
Correction
Published on 11 Jul 2025
Correction: Novel multitarget analgesic candidate SZV-1287 demonstrates potential disease-modifying effects in the monoiodoacetate-induced osteoarthritis mouse model
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1646562
- 1,263 views
- 1 citation
Original Research
Published on 11 Jul 2025
Ursolic acid ameliorates cerebral ischemia-reperfusion injury by inhibiting NF-κB/NLRP3-mediated microglia pyroptosis and neuroinflammation
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1622131
- 3,527 views
- 1 citation
Original Research
Published on 11 Jul 2025
Ramipril and ketogenic diet response in cognitive dysfunction of insulin-resistant rats
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1620139
- 1,661 views
Original Research
Published on 07 Jul 2025
Exploration of the potential neurotransmitter or neuromodulator-like properties of harmine: evidence from synthesis to synaptic modulation
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1588105
- 2,834 views
Original Research
Published on 07 Jul 2025
The kynurenine pathway as a potential link between ethanol-induced behavioral alterations and neuroinflammation
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1628527
- 2,224 views
Original Research
Published on 02 Jul 2025
Dexmedetomidine potently and reversibly regulates stress-mediated behaviors
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1589075
- 3,270 views
- 1 citation
Hypothesis and Theory
Published on 02 Jul 2025
The antipsychotics functional index (AFI) in schizophrenia
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1591763
- 2,687 views
Original Research
Published on 02 Jul 2025
Acute pharmacological effects of α-PVP in humans: a naturalistic observational study
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1626692
- 7,457 views
Mini Review
Published on 01 Jul 2025
Clinical characterization and management of persons with comorbid epilepsy and depression: an expert opinion paper
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1592650
- 2,318 views
- 1 citation
Original Research
Published on 01 Jul 2025
Glutamatergic mechanisms in early salience processing
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1601797
- 1,553 views
Review
Published on 30 Jun 2025
Orexin-A and motion sickness: a systematic review of animal model studies
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1624080
- 2,171 views
Review
Published on 27 Jun 2025
Preclinical and experimental evidence of salvianolic acid B in the treatment of neurological diseases
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1606146
- 3,528 views
Original Research
Published on 26 Jun 2025
Validating the antiseizure effects of vitexin and related flavone glycosides in zebrafish
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1628324
- 2,246 views
- 1 citation